New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951-Reference-Cited by-同舟云学术

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

Published:2013-11 Issue:16 Volume:49 Page:3477-3485
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gorlia Thierry,Delattre Jean-Yves,Brandes Alba A.,Kros Johan M.,Taphoorn Martin J.B.,Kouwenhoven Mathilde C.M.,Bernsen H.J.J.A.,Frénay Marc,Tijssen Cees C.,Lacombe Denis,van den Bent Martin J.

Funder

National Cancer Institute

Kankerbestrijding/KWF

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC Brain Tumor Group Study 26951;van den Bent;J Clin Oncol,2012

2. A phase 3 trial of chemo-radiotherapy for anaplastic oligodendroglioma: long term results of RTOG 9402;Cairncross;J Clin Oncol,2012

3. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective;van den Bent;Acta Neuropathol,2010

4. Panel review of anaplastic oligodendroglioma from European Organization for Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome;Kros;J Neuropathol Exp Neurol,2007

5. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group;van den Bent;Clin Cancer Res,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis;Journal of Neuro-Oncology;2023-09

2. A novel gene, TARDBP, and the protein it encodes can predict glioma patient prognosis and establish a prediction model;BMC Neurology;2023-05-06

3. Investigating survival, quality of life and cognition in PROton versus photon therapy forIDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden;BMJ Open;2023-03

4. Prognosis of overall and disease-free survival in patients with grade 3 astrocytomas (anaplastic astrocytoma, WHO 2016);Voprosy neirokhirurgii imeni N.N. Burdenko;2023

5. Large infratentorial cystic oligodendroglioma in a pregnant patient: A case report of a rare presentation and literature review;Clinical Case Reports;2022-06